Drug Information Analysis Service

Tabachnik E Levison H . Infantile bronchial asthma. J Allergy Clin Immunol 1981; 67: 339–47.

Konig P . Treatment considerations in children aged 0–5 years. Lung 1990; 168 (suppl):S241–5.

Twarog FJ . Treatment of the wheezing infant. In: Tinkelman DG Falliers CJ Naspitz CK , eds. Childhood asthma. New York: Marcel Dekker; 1987: 160–81.

Sweeney GD MacLeod SM . Anti-allergy and anti-asthma drugs: Disposition in infancy and childhood. Clin Pharmacokinet 1989; 17 (suppl 1):S156–68.

Zeiger RS . Special considerations in the approach to asthma in infancy and early childhood. J Asthma 1983; 20: 341–59.

Rall TW . Drugs used in the treatment of asthma. In: Goodman AG Rall TW Nies AS Taylor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. Elmsford: Pergamon Press; 1990: 618–35.

Warner JO Gotz M Landau LI Levison H Milner AD Pedersen S Management of asthma: A consensus statement. Arch Dis Child 1989; 64: 1065–79.

National Asthma Education Program. Office of Prevention, Education, and Control, National Heart, Lung, and Blood Institute. Executive summary: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1991.

Henry RL Hiller EJ Milner AD Hodges JGC Stokes GM . Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child 1984; 59: 54–7.

Geller-Bernstein C Levin S . Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration 1982; 43: 294–8.

Yuksel B Greenough A . Inhaled sodium cromoglycate for pre-term children with respiratory symptoms at follow-up. Resp Med 1992; 86: 131–4.

Mok J Levison H . The wheezing infant. In: Tinkelman DG Falliers CJ Naspitz CK , eds. Childhood asthma. New York: Marcel Dekker; 1987: 160–81.

Salmon B Wilson NM Silverman M . How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child 1990; 65: 401–3.

Grigg J Arnon S Jones T Clarke A Silverman M . Delivery of therapeutic aerosols to intubated babies. Arch Dis Child 1992; 67: 25–30.

Lewis GM Lewis RA . The place of nebulisers in childhood asthma. Postgrad Doctor Middle East 1984; 7: 315–25.

Levison H Reilly PA Worsley GH . Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr 1985; 107: 662–8.

Henry RL Milner AD . Simple drug delivery system for use by young asthmatics. Br Med J 1983; 286: 2021.

O'Callaghan C Milner AD Swarbrick A . Nebulised sodium cromoglycate in infancy: Airway protection after deterioration. Arch Dis Child 1991; 65: 404–6.

Mueller GA Eigen H . Pediatric pulmonary function testing in asthma. Pediatr Clin North Am 1992; 39: 1243–58.

Martin A . Clinical management of lithium-induced polyuria. Hosp Community Psychiatry 1993; 44: 427–8.

Lee RV Jampol LM Brown WV . Nephrogenic diabetes insipidus and lithium intoxication: Complications of lithium carbonate therapy. N Engl J Med 1971; 284: 93–4.

Baraban JM Worley PF Snyder SH . Second messenger systems and psychoactive drug action: Focus on the phosphoinositide system and lithium. Am J Psychiatry 1989; 146: 1251–60.

Kosten TR Forrest JN . Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatry 1986; 143: 1563–8.

Baba WI Land AF Smith AJ . Pharmacologic effects in animals and normal human subjects of the diuretic amiloride hydrochloride. Clin Pharmacol Ther 1968; 9: 318–27.

Batlle DC von Riotte AB Gaviria M Grupp M . Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408–14.

Dorevitch A Baruch E . Lithium toxicity induced by combined amiloride HCl—hydrochlorothiazide administration (letter). Am J Psychiatry 1986; 143: 257–8.

Maj M Starace F Nolfe G . Minimum plasma lithium levels required for effective prophylaxis in DSM-III bipolar disorder: A prospective study. Pharmacopsychiatry 1986; 19: 420–3.

Plenge P Mellerup ET Bolwig TG . Lithium treatment: Does the kidney prefer one daily dose instead of two? Acta Psychiatr Scand 1982; 66: 121–8.

Klemfuss H . Diminishing toxic effects of lithium administration (letter). Am J Psychiatry 1992; 149: 846.

Jefferson JW . Potassium supplementation in lithium patients: A timely intervention or premature speculation? J Clin Psychiatry 1992; 53: 370–2.

Grindlinger GA Boylan MJ . Amelioration by indomethacin of lithium-induced polyuria. Crit Care Med 1987; 15: 538–9.

Clinical pharmacokinetics: pharmacokinetics of clonidine. Auckland, NZ: ADIS Press Limited, May 1988: 287–310.

Hollifield J . Clinical acceptability of transdermal clonidine: A large-scale evaluation by practitioners. Am Heart J 1986; 112: 900–6.

AHFS drug information, 1992. Bethesda, MD: American Society of Hospital Pharmacists, 1992: 966–9, 2139–40.

Holdiness MR . A review of contact dermatitis associated with transdermal therapeutic systems. Contact Dermatitis 1989; 20: 3–9.

Hogan DJ . Review of contact dermatitis for non-dermatologists. J Fla Med Assoc 1990; 77: 663–6.

Maibach HI . Oral substitution in patients sensitized by transdermal clonidine treatment. Contact Dermatitis 1987; 16: 1–8.

Management of dermatitis associated with Catapres-TTS (clonidine) transdermal therapeutic system. Ridgefield, CT: Boehringer Ingelheim, 1985: 1–8.

Ito MK O'Connor DT . Skin pretreatment and the use of transdermal clonidine. Am J Med 1991; 91 (suppl A):42S–9S.

McChesney JA . Preventing the contact dermatitis caused by a transdermal clonidine patch (letter). West J Med 1991; 154: 736.

Rushton DH . Management of hair loss in women. Dermatol Clin 1993; 11: 47–53.

Maguire HC Kligman AM . Common baldness in women. Geriatrics 1963: 329–34.

Ludwig E . Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247–54.

Headington JT . Hair follicle biology and topical minoxidil: Possible mechanisms of action. Dermatologica 1987; 175 (suppl 2):19–22.

Savin RC Atton AV . Minoxidil: Update on its clinical role. Dermatol Ther 1993; 11: 55–64.

DeVillez RL . The therapeutic use of topical minoxidil. Dermatol Clin 1990; 8: 367–75.

Price VH Menefee E . Quantitative estimation of hair growth. I. Androgenetic alopecia in women: Effect of minoxidil. Invest Dermatol 1990; 95: 683–7.

Olsen EA . Topical minoxidil in the treatment of androgenetic alopecia in women. Cutis 1991; 48: 243–8.

Katz HI . Topical minoxidil: Review of efficacy and safety. Cutis 1989; 43: 94–8.

Whiting DA Jacobson C . Treatment of female androgenetic alopecia with minoxidil 2%. Int J Dermatol 1992; 31: 800–4.

Jacobs JP Szpunar CA Warner ML . Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 1993; 32: 758–62.

Whitney TM Lineaweaver WC Billys JB Siko PP Buncke GM Alpert BS . Improved salvage of complicated microvascular transplants monitored with quantitative fluorometry. Plast Reconstr Surg 1991; 90: 105–11.

Furnas H Rosen JM . Monitoring in microvascular surgery. Ann Plast Surg 1991; 26: 265–72.

Levinsohn DG Gordon L Sessler DI . Comparison of four objective methods of monitoring digital venous congestion. J Hand Surg 1991; 16A: 1056–62.

Copeland J Harman RD Wells HG Puckett CL . Quantitative fluorometry as a monitor for microvascular surgery. J Hand Surg 1987; 12A: 250–5.

Fluorescein. In: Budavari S , ed. Merck index. 11th ed. Rahway, NJ: Merck, 1989: 651.

McGraw JB Myers B Shanklin KD . The value of fluorescein in predicting the viability of arterialized flaps. Plast Reconstr Surg 1977; 60: 710–9.

Lange K Boyd LJ . The use of fluorescein to determine the adequacy of the circulation. Med Clin North Am 1942; 26: 943–52.

Graham BH Gordon L Alpert BS Walton R Buncke HJ Leitner DW . Serial quantitative skin surface fluorescence: A new method for postoperative monitoring of vascular perfusion in revascularized digits. J Hand Surg 1985; 10A: 226–30.